CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction

Basic Research in Cardiology

Volumn 108, Issue 6, 2013, Pages

  Hausding, Michael ^a   Jurk, Kerstin ^a   Daub, Steffen ^a   Kröller Schön, Swenja ^a   Stein, Judith ^a   Schwenk, Melanie ^a   Oelze, Matthias ^a   Mikhed, Yuliya ^a   Kerahrodi, Jasmin Ghaemi ^a   Kossmann, Sabine ^a   Jansen, Thomas ^a   Schulz, Eberhard ^a   Wenzel, Philip ^a   Reske Kunz, Angelika B ^a   Becker, Christian ^a   Münzel, Thomas ^a   Grabbe, Stephan ^a   Daiber, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Bleeding time; Endothelial function; Immune cell infiltration; Phagocytic NADPH oxidase; Platelet activation; Vascular inflammation

Indexed keywords

ANGIOTENSIN II; CD40 LIGAND; CYTOKINE; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THROMBIN; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BLEEDING TIME; BLOOD CLOTTING; BLOOD VESSEL FUNCTION; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; IMMUNOCOMPETENT CELL; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULITIS;

ANGIOTENSIN II; ANIMALS; AORTA; BLOTTING, WESTERN; CD40 LIGAND; ENDOTHELIAL CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PLATELET ACTIVATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSIS; VASCULAR DISEASES;

EID: 84890305583     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0386-5     Document Type: Article

References (59)

1. Akasaki T, Ohya Y, Kuroda J, Eto K, Abe I, Sumimoto H, Iida M (2006) Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens Res 29:813-820. doi: 10.1291/hypres.29.813 (Pubitemid 44842817)
2. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8:247-252. doi: 10.1038/nm0302-247 (Pubitemid 34250102)
3. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C (2009) The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 54:669-677. doi: 10.1016/j.jacc.2009.03.076
4. Atochina O, Harn D (2005) LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol 12:1041-1049. doi: 10.1128/CDLI.12.9.1041-1049.2005 (Pubitemid 41324534)
5. Bavendiek U, Zirlik A, LaClair S, MacFarlane L, Libby P, Schonbeck U (2005) Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells. Arterioscler Thromb Vasc Biol 25:1244-1249. doi: 10.1161/01.ATV.0000161420.55482.ef (Pubitemid 40776616)
6. Crow AR, Leytin V, Starkey AF, Rand ML, Lazarus AH (2003) CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates. J Thromb Haemost 1:850-852. doi: 10.1046/j.1538-7836.2003.t01-1-00115.x
7. Daiber A, August M, Baldus S, Wendt M, Oelze M, Sydow K, Kleschyov AL, Munzel T (2004) Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic Biol Med 36:101-111. doi: 10.1016/j.freeradbiomed.2003.09.023 (Pubitemid 38068290)
8. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T (2004) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 66:1372-1382. doi: 10.1124/mol.104.002600 (Pubitemid 39564764)
9. Davis B, Zou MH (2005) CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo. Circulation 112:2184-2192. doi: 10.1161/CIRCULATIONAHA.105.553206 (Pubitemid 41475814)
10. Donners MM, Beckers L, Lievens D, Munnix I, Heemskerk J, Janssen BJ, Wijnands E, Cleutjens J, Zernecke A, Weber C, Ahonen CL, Benbow U, Newby AC, Noelle RJ, Daemen MJ, Lutgens E (2008) The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 111:4596-4604. doi: 10.1182/blood-2007-05-088906
11. Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, Hakimi M, Bockler D, Katus HA, Gleissner CA (2011) Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol 106:125-134. doi: 10.1007/s00395-010-0135-y
12. Ferroni P, Guadagni F (2008) Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications. Cardiovasc Hematol Disord: Drug Targets 8:194-202. doi: 10.2174/187152908785849125
13. Ferroni P, Guagnano MT, Falco A, Paoletti V, Manigrasso MR, Michetti N, Santilli F, Guadagni F, Basili S, Davi G (2008) Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci (Lond) 114:449-455. doi: 10.1042/CS20070307 (Pubitemid 351397394)
14. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 191:1413-1422. doi: 10.1084/jem.191.8.1413 (Pubitemid 30227127)
15. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148. doi: 10.1161/01.RES.74.6.1141 (Pubitemid 24176909)
16. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449-2460. doi: 10.1084/jem.20070657 (Pubitemid 47529329)
17. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM (2011) Inflammation, immunity, and hypertension. Hypertension 57:132-140. doi: 10.1161/HYPERTENSIONAHA.110.163576
18. Hassan GS, Merhi Y, Mourad W (2012) CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology 217:521-532. doi: 10.1016/j.imbio.2011.03.010
19. Jagroop IA, Mikhailidis DP (2000) Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 14:581-585. doi: 10.1038/sj.jhh.1001102
20. Jurk K, Ritter MA, Schriek C, Van Aken H, Droste DW, Ringelstein EB, Kehrel BE (2010) Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis. Thromb Haemost 103:1193-1202. doi: 10.1160/TH09-09-0620
21. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB (2000) Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6:114. doi: 10.1038/72162 (Pubitemid 30082329)
22. Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, Levkau B (2011) Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 108:314-323. doi: 10.1161/CIRCRESAHA.110.235028
23. Kleschyov AL, Munzel T (2002) Advanced spin trapping of vascular nitric oxide using colloid iron diethyldithiocarbamate. Methods Enzymol 359:42-51. doi: 10.1016/S0076-6879(02)59170-9 (Pubitemid 35387008)
24. Koguchi Y, Thauland TJ, Slifka MK, Parker DC (2007) Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood 110:2520-2527. doi: 10.1182/blood-2007-03-081299 (Pubitemid 47523174)
25. Kossmann S, Schwenk M, Hausding M, Karbach SH, Schmidgen MI, Brandt M, Knorr M, Hu H, Kroller-Schon S, Schonfelder T, Grabbe S, Oelze M, Daiber A, Munzel T, Becker C, Wenzel P (2013) Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells. Arterioscler Thromb Vasc Biol 33:1313-1319. doi: 10.1161/ATVBAHA.113.301437
26. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W (1999) Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1623-1629. doi: 10.1161/01.ATV.19.7.1623 (Pubitemid 29323820)
27. Kroller-Schon S, Knorr M, Hausding M, Oelze M, Schuff A, Schell R, Sudowe S, Scholz A, Daub S, Karbach S, Kossmann S, Gori T, Wenzel P, Schulz E, Grabbe S, Klein T, Munzel T, Daiber A (2012) Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition. Cardiovasc Res 96:140-149. doi: 10.1093/cvr/cvs246
28. Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, Xia N, Hausding M, Mikhed Y, Zinssius E, Mader M, Stamm P, Treiber N, Scharffetter-Kochanek K, Li H, Schulz E, Wenzel P, Munzel T, Daiber A (2013) Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species - studies in white blood cells and in animal models. Antioxid Redox Signal. doi: 10.1089/ars.2012.4953
29. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511-515. doi: 10.1161/01.HYP.0000032100.23772.98
30. Li G, Sanders JM, Bevard MH, Sun Z, Chumley JW, Galkina EV, Ley K, Sarembock IJ (2008) CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 172:1141-1152. doi: 10.2353/ajpath.2008.070633 (Pubitemid 351520009)
31. Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC, Wijnands E, Goossens P, van Kruchten R, Thevissen L, Boon L, Flavell RA, Noelle RJ, Gerdes N, Biessen EA, Daemen MJ, Heemskerk JW, Weber C, Lutgens E (2010) Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116:4317-4327. doi: 10.1182/blood-2010-01-261206
32. Lutgens E, Lievens D, Beckers L, Wijnands E, Soehnlein O, Zernecke A, Seijkens T, Engel D, Cleutjens J, Keller AM, Naik SH, Boon L, Oufella HA, Mallat Z, Ahonen CL, Noelle RJ, de Winther MP, Daemen MJ, Biessen EA, Weber C (2010) Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 207:391-404. doi: 10.1084/jem.20091293
33. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96:396-399. doi: 10.1161/01.CIR.96.2.396 (Pubitemid 27329409)
34. Martinet W, De Meyer I, Verheye S, Schrijvers DM, Timmermans JP, De Meyer GR (2013) Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic Res Cardiol 108:321. doi: 10.1007/s00395-012-0321-1
35. Martinet W, Schrijvers DM, De Meyer GR (2012) Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Res Cardiol 107:297. doi: 10.1007/s00395-012-0297-x
36. Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760. doi: 10.1007/s00395-011-0192-x
37. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58-E65. doi: 10.1161/01.RES.0000012569.55432. 02
38. Morawietz H (2011) Endothelial NADPH oxidases: friends or foes? Basic Res Cardiol 106:521-525. doi: 10.1007/s00395-011-0188-6
39. Nagashima H, Aoka Y, Sakomura Y, Uto K, Sakuta A, Aomi S, Kurosawa H, Hagiwara N, Kawana M, Kasanuki H (2004) Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. J Vasc Surg 39:447-453. doi: 10.1016/j.jvs.2003.07.005 (Pubitemid 38174332)
40. Oelze M, Knorr M, Schell R, Kamuf J, Pautz A, Art J, Wenzel P, Munzel T, Kleinert H, Daiber A (2011) Regulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro. J Biol Chem 286:8893-8900. doi: 10.1074/jbc.M110.190017
41. Oelze M, Schuhmacher S, Daiber A (2010) Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate. Exp Diabetes Res 2010:213176. doi: 10.1155/2010/213176
42. Ohishi M, Dusting GJ, Fennessy PA, Mendelsohn FA, Li XC, Zhuo JL (2010) Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries. Int J Physiol Pathophysiol Pharmacol 2:111-124
43. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ (2004) CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22:307-328. doi: 10.1146/annurev.immunol.22.012703.104533 (Pubitemid 38680425)
44. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923. doi: 10.1172/JCI118623
45. Renshaw BR, Fanslow WC 3rd, Armitage RJ, Campbell KA, Liggitt D, Wright B, Davison BL, Maliszewski CR (1994) Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 180:1889-1900. doi: 10.1084/jem.180.5.1889 (Pubitemid 24328578)
46. Ruef J, Browatzki M, Pfeiffer CA, Schmidt J, Kranzhofer R (2007) Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2. Vasc Med 12:23-27. doi: 10.1177/1358863X07076766 (Pubitemid 46578785)
47. Schildknecht S, Heinz K, Daiber A, Hamacher J, Kavakli C, Ullrich V, Bachschmid M (2006) Autocatalytic tyrosine nitration of prostaglandin endoperoxide synthase-2 in LPS-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun 340:318-325. doi: 10.1016/j.bbrc.2005.12.009 (Pubitemid 41827683)
48. Schuhmacher S, Foretz M, Knorr M, Jansen T, Hortmann M, Wenzel P, Oelze M, Kleschyov AL, Daiber A, Keaney JF Jr, Wegener G, Lackner K, Munzel T, Viollet B, Schulz E (2011) alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol 31:560-566. doi: 10.1161/ATVBAHA.110.219543
49. Schuhmacher S, Schulz E, Oelze M, Konig A, Roegler C, Lange K, Sydow L, Kawamoto T, Wenzel P, Munzel T, Lehmann J, Daiber A (2009) A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena. Br J Pharmacol 158:510-520. doi: 10.1111/j.1476-5381.2009.00303.x
50. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, Wenzel P, Munzel T, Keaney JF Jr (2008) Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 118:1347-1357. doi: 10.1161/CIRCULATIONAHA.108.784298
51. Sirker A, Zhang M, Shah AM (2011) NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106:735-747. doi: 10.1007/s00395-011-0190-z
52. Siuda D, Zechner U, El Hajj N, Prawitt D, Langer D, Xia N, Horke S, Pautz A, Kleinert H, Forstermann U, Li H (2012) Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells. Basic Res Cardiol 107:283. doi: 10.1007/s00395-012-0283-3
53. Strassel C, Nonne C, Eckly A, David T, Leon C, Freund M, Cazenave JP, Gachet C, Lanza F (2007) Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome. Arterioscler Thromb Vasc Biol 27:241-247. doi: 10.1161/01.ATV.0000251992.47053.75 (Pubitemid 46360405)
54. Tchaikovski SN, van Vlijmen BJ, Rosing J, Tans G (2007) Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J Thromb Haemost 5:2079-2086. doi: 10.1111/j.1538-7836.2007.02719.x (Pubitemid 47450027)
55. Wagner AH, Guldenzoph B, Lienenluke B, Hecker M (2004) CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 24:715-720. doi: 10.1161/01.ATV.0000122853.99978.b1 (Pubitemid 38451609)
56. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, Daiber A (2007) Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 282:792-799. doi: 10.1074/jbc.M606477200 (Pubitemid 47076617)
57. Wenzel P, Knorr M, Kossmann S, Stratmann J, Hausding M, Schuhmacher S, Karbach SH, Schwenk M, Yogev N, Schulz E, Oelze M, Grabbe S, Jonuleit H, Becker C, Daiber A, Waisman A, Munzel T (2011) Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 124:1370-1381. doi: 10.1161/CIRCULATIONAHA.111.034470
58. Wenzel P, Schulz E, Oelze M, Muller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, Munzel T, Daiber A (2008) AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 45:619-626. doi: 10.1016/j.freeradbiomed.2008.05.009
59. Wolf D, Hohmann JD, Wiedemann A, Bledzka K, Blankenbach H, Marchini T, Gutte K, Zeschky K, Bassler N, Hoppe N, Rodriguez AO, Herr N, Hilgendorf I, Stachon P, Willecke F, Duerschmied D, von zur Muhlen C, Soloviev DA, Zhang L, Bode C, Plow EF, Libby P, Peter K, Zirlik A (2011) Binding of CD40L to Mac-1′s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis - but does not affect immunity and thrombosis in mice. Circ Res 109:1269-1279. doi: 10.1161/CIRCRESAHA.111.247684